Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katelyn J. Hammond"'
Autor:
David T. Scadden, Kevin A. Goncalves, Veit Schmelmer, Haley Howell, Steven M. Devine, Jonathan Hoggatt, Jan Pinkas, Patrick C. Falahee, William J. Savage, Sharon L. Hyzy, John F. DiPersio, Katelyn J. Hammond, John C. Davis
Publikováno v:
Blood. 136:31-32
Background . The majority of hematopoietic stem cell (HSC) transplants are performed using peripheral blood mobilized with granulocyte-colony stimulating factor (G-CSF) given over 5 days. The goal of a successful transplant is to reliably mobilize op
Autor:
David T. Scadden, Jonathan Hoggatt, Sharon L. Hyzy, Veit Schmelmer, Jan Pinkas, Patrick C. Falahee, Haley Howell, Kevin A. Goncalves, John C. Davis, William J. Savage, John F. DiPersio, Steven M. Devine, Katelyn J. Hammond
Publikováno v:
Transplantation and Cellular Therapy. 27:S34
Autor:
Rahul Palchaudhuri, Ganapathy N. Sarma, Bradley R. Pearse, Tahirih L. Lamothe, Bruce R. Blazar, John C. Davis, Geoffrey O. Gillard, Katelyn J. Hammond, Anthony E. Boitano, Asim Saha, Charlotte Mcdonagh, Jennifer L. Proctor, Michael P. Cooke, Sharon L. Hyzy, Nicholas M. Clark, Hans-Peter Kiem, John E. Wagner
Publikováno v:
Transplantation and Cellular Therapy. 27:S217
Autor:
Nicholas M. Clark, Hans-Peter Kiem, Anthony E. Boitano, Jennifer L. Proctor, Katelyn J. Hammond, Charlotte Mcdonagh, Anjali Bhat, Geoff O Gillard, Rahul Palchaudhuri, Tahirih L. Lamothe, Ganapathy N. Sarma, Sharon L. Hyzy, Bradley R. Pearse, Bruce R. Blazar, John C. Davis, John E. Wagner, Michael P. Cooke, Asim Saha
Publikováno v:
Blood. 136:31-31
Introduction Allogeneic hematopoietic stem cell transplant (Allo-HSCT) is a potentially curative treatment for malignant and non-malignant blood disorders. However, current conditioning regimens limit the use of this curative procedure in many eligib
Autor:
Rahul Palchaudhuri, Ganapathy N. Sarma, Melissa L. Brooks, Bradley R. Pearse, Bruce R. Blazar, Geoff O Gillard, Sharon L. Hyzy, Nicholas M. Clark, Hans-Peter Kiem, Anthony E. Boitano, John E. Wagner, Katelyn J. Hammond, Tahirih L. Lamothe, Asim Saha, Charlotte Mcdonagh, Anjali Bhat, Michael P. Cooke, Jennifer L. Proctor
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S160
Introduction Allogeneic hematopoietic stem cell transplant (Allo-HSCT) is a potentially curative treatment for malignant and non-malignant blood disorders. However, current conditioning regimens limit its use due to regimen-related mortality and morb